Philippe Spiess, Assistant Chief of Surgery and Senior Member at Deptartment of GU Oncology at Moffitt Cancer Center, shared a post on X by Ashish Kamat, Professor and Director of Urologic Oncology Fellowship at MD Anderson Cancer Center, adding:
“A truly engaging and evidence based discussion by global thought leaders on the use of biomarkers in GU oncology establishing our current state of the art standards and future founding principles for adoption in clinical practice.”
Quoting Ashish Kamat’s post:
“It’s a wrap! Thanks to everyone who joined in person and online for turning this into a focused effort that was energizing, data driven, and genuinely worthwhile.”
More posts featuring Philippe Spiess and Ashish M. Kamat.